Achieving sustained virological response after direct-acting antiviral therapy reduces liver-related events among those with decompensated HCV cirrhosis.
Kelowna mother Lyndsay Richholt was told in March that she has approximately six months to live, her fate now resting on ...
10d
This woman had to campaign to find a liver donor. Transplant docs say there should be a better way
It's pretty unusual in the medical system for a patient to be tasked with finding their own cure. But that’s what happened to ...
Pharmaceutical Technology on MSN
Aldeyra reshuffles pipeline, culling asset despite Phase II success
Despite ADX-629 meeting all its endpoints in a Phase II trial, Aldeyra is culling the asset as part of a pipeline ...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback